Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
By Roy H. Perlis, M. Ostacher, J. Patel, L. Marangell, Hongwei Zhang, S. Wisniewski, T. Ketter, D. Miklowitz, M. Otto, L. Gyulai and 4 more. American Journal of Psychiatry, 2006
642 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/01632e0acfa4f41e7c56c28a81e425288fb5b1ee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Psychiatry and Mental health
Citations in the corpus
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. (2009, background): “In the STEP-BD study, residual depressive or manic symptoms at recovery and proportion of days depressed or anxious in the preceding year predicted depressive recurrence, and residual manic symptoms at recovery and proportion of days of elevated mood in the preceding year predicted manic, hypomanic,”
- Creative Mythconceptions: A Closer Look at the Evidence for the "Mad Genius" Hypothesis (2009, background): “…has been so thoroughly elasticized that it captures virtually anyone who’s ever had a mood at all; it is 3 It turns out that a major finding of the STEP-BD study was that we still lack the tools and treatments to prevent 90% of bipolars from suffering a recurrence (Perlis et al., 2006, p. 222).”
- College Students: Mental Health Problems and Treatment Considerations (2014, background): “Similarly, an earlier onset of bipolar disorder is more problematic as it is associated with higher risk for co-occurring psychiatric and substance use disorders, less lithium responsiveness, more mixed presentations, and increased illness burden [74–79].”